Cargando…
Impact of Contextual-Level Social Determinants of Health on Newer Antidiabetic Drug Adoption in Patients with Type 2 Diabetes
Background: We aimed to investigate the association between contextual-level social determinants of health (SDoH) and the use of novel antidiabetic drugs (ADD), including sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1a) for patients with type 2...
Autores principales: | Li, Yujia, Hu, Hui, Zheng, Yi, Donahoo, William Troy, Guo, Yi, Xu, Jie, Chen, Wei-Han, Liu, Ning, Shenkman, Elisabeth A., Bian, Jiang, Guo, Jingchuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001625/ https://www.ncbi.nlm.nih.gov/pubmed/36901047 http://dx.doi.org/10.3390/ijerph20054036 |
Ejemplares similares
-
Newer antidiabetic drugs and calorie restriction mimicry
por: Kalra, Sanjay, et al.
Publicado: (2016) -
Red carpeting the newer antidiabetics
por: Gude, Dilip
Publicado: (2012) -
Ethnic Variations in Cardiovascular and Renal Outcomes From Newer Glucose‐Lowering Drugs: A Meta‐Analysis of Randomized Outcome Trials
por: Tang, Huilin, et al.
Publicado: (2023) -
Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients
por: Mudher Mikhael, Ehab
Publicado: (2016) -
Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis
por: Batzias, Konstantinos, et al.
Publicado: (2018)